Exact Mass: 364.1287

Exact Mass Matches: 364.1287

Found 150 metabolites which its exact mass value is equals to given mass value 364.1287, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pyridaben

4-Chloro-2-(1,1-dimethylethyl)-5-(((4-(1,1-dimethylethyl)phenyl)methyl)thio)-3(2H)-pyridazinone

C19H25ClN2OS (364.1376)


CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10598; ORIGINAL_PRECURSOR_SCAN_NO 10596 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10636; ORIGINAL_PRECURSOR_SCAN_NO 10634 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10546; ORIGINAL_PRECURSOR_SCAN_NO 10544 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10660; ORIGINAL_PRECURSOR_SCAN_NO 10659 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10708; ORIGINAL_PRECURSOR_SCAN_NO 10707 CONFIDENCE standard compound; INTERNAL_ID 331; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10670; ORIGINAL_PRECURSOR_SCAN_NO 10667 CONFIDENCE standard compound; INTERNAL_ID 2632

   

hydroxytorsemide

N-[(4-{[3-(hydroxymethyl)phenyl]imino}-1,4-dihydropyridin-3-yl)sulfonyl]propane-2-carbamimidic acid

C16H20N4O4S (364.1205)


hydroxytorsemide is a metabolite of torasemide. Torasemide or torsemide is a pyridine-sulfonyl urea type loop diuretic mainly used in the management of edema associated with congestive heart failure. It is also used at low doses for the management of hypertension. It is marketed under the brand name Demadex and Diuver. Compared to other loop diuretics, torasemide has a more prolonged diuretic effect than equipotent doses of furosemide and relatively decreased potassium-loss. (Wikipedia)

   

(1R,4Ar,5S,7R)-7-methyl-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol

(1R,4Ar,5S,7R)-7-methyl-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol

C15H24O10 (364.1369)


   

Clofoctol

2-[(2,4-dichlorophenyl)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol

C21H26Cl2O (364.1361)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use C254 - Anti-Infective Agent > C52588 - Antibacterial Agent Clofoctol is a bacteriostatic antibiotic. Clofoctol is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. Clofoctol is only functional against Gram-positive bacteria and can penetrate into human lung tissue. Clofoctol is also an inhibitor of prostate cancer. Clofoctol has antiviral potency[1][2][3].

   

Diaziquone

ethyl N-[2,5-bis(aziridin-1-yl)-4-[(ethoxycarbonyl)amino]-3,6-dioxocyclohexa-1,4-dien-1-yl]carbamate

C16H20N4O6 (364.1383)


   

N'-[2-(3,5-Difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide

2-(3,5-difluorophenyl)-N-(2-ethyl-4-hydroxy-3-methylbenzoyl)-2-hydroxyacetohydrazide

C18H18F2N2O4 (364.1235)


   

Popop

5-phenyl-2-[4-(5-phenyl-1,3-oxazol-2-yl)phenyl]-1,3-oxazole

C24H16N2O2 (364.1212)


   

Ajugol

(1S-(1alpha,4aalpha,5alpha,7alpha,7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5,7-trihydroxy-7-methylcyclopenta(c)pyran-1-yl beta-D-glucopyranoside

C15H24O10 (364.1369)


Harpagide is a natural product found in Scrophularia leucoclada, Scrophularia variegata, and other organisms with data available. See also: Harpagophytum zeyheri root (part of). Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2]. Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2].

   

harpagide

(7S)-4a,5,7-trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl D-glucopyranoside

C15H24O10 (364.1369)


Origin: Plant; SubCategory_DNP: Monoterpenoids, Harpagide monoterpenoids Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2]. Harpagide is a class of iridoid glycoside isolated from Scrophularia ningpoensis and has antiparasitic activity, which exhibits good in vitro trypanocidal activities against African trypanosomes (T.b. rhodesiense) with an IC50 of 21 μg/mL. Harpagide exerts significant antileishmanial activity against L. donovani with an IC50 value of 2.0 μg/mL. Harpagide also possess significant anti-inflammatory activities[1][2].

   

6-methoxycalpogonium isoflavone A

6,4-Dimethoxy-6,6-dimethylpyrano[2,3:7,8]isoflavone

C22H20O5 (364.1311)


   

Dihydrocatalpol

Dihydrocatalpol

C15H24O10 (364.1369)


   

Thonninginisoflavone

5,4-Dimethoxy-5-(1-methylethenyl)-4,5-dihydrofurano[2,3:7,6]isoflavone

C22H20O5 (364.1311)


   

Gnetupendin A

Gnetupendin A

C22H20O5 (364.1311)


   

Kankanoside B

Kankanoside B

C15H24O10 (364.1369)


   

Stegioside III

Stegioside III

C15H24O10 (364.1369)


   

Rhinacanthin M

Rhinacanthin M

C22H20O5 (364.1311)


   

Carpachromene dimethyl ether

5-Methoxy-8- (4-methoxyphenyl) -2,2-dimethyl-2H,6H-benzo [ 1,2-b:5,4-b ] dipyran-6-one

C22H20O5 (364.1311)


   

3,5-Dimethoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one

3,5-Dimethoxy-8,8-dimethyl-2-phenyl-4H,8H-benzo [ 1,2-b:3,4-b ] dipyran-4-one

C22H20O5 (364.1311)


   

Alpinumisoflavone dimethyl ether

Alpinumisoflavone dimethyl ether

C22H20O5 (364.1311)


   

3,6-Dimethoxy-6,6-dimethylpyrano[2,3:7,8]flavone

3,6-Dimethoxy-6",6"-dimethylpyrano [ 2,3:7,8 ] flavone

C22H20O5 (364.1311)


   

Bracteflavone A

Bracteflavone A

C22H20O5 (364.1311)


   

Oprea1_078902

Oprea1_078902

C23H16N4O (364.1324)


   

Maybridge4_000286

Maybridge4_000286

C21H20N2O2S (364.1245)


   

6-Methoxycalopogoniumisoflavone A

6-Methoxycalopogoniumisoflavone A

C22H20O5 (364.1311)


   

(8S)-(-)-7,8-Dihydro-8-hydroxyaucubin|5,7-bisdeoxy-cynanchoside|5,7-bisdeoxycynanchoside

(8S)-(-)-7,8-Dihydro-8-hydroxyaucubin|5,7-bisdeoxy-cynanchoside|5,7-bisdeoxycynanchoside

C15H24O10 (364.1369)


   
   

C1=CC(O)=C2C(OC)C(OC)C3C4=CC=C(O)C(C(=O)CC5)=C4C5=C3C2=C1

C1=CC(O)=C2C(OC)C(OC)C3C4=CC=C(O)C(C(=O)CC5)=C4C5=C3C2=C1

C22H20O5 (364.1311)


   

Di-O-methylcarpachromene

Di-O-methylcarpachromene

C22H20O5 (364.1311)


   

3-ethoxy-1,4,9-trihydroxy-1,2,3,6b-tetrahydrobenzo[j]fluoranthen-8(7H)-one|hypoxylonol A

3-ethoxy-1,4,9-trihydroxy-1,2,3,6b-tetrahydrobenzo[j]fluoranthen-8(7H)-one|hypoxylonol A

C22H20O5 (364.1311)


   

Griffonianone F

Griffonianone F

C22H20O5 (364.1311)


   

Fluorgibberellinsaeure

Fluorgibberellinsaeure

C19H21FO6 (364.1322)


   

Glabrone dimethyl ether

Glabrone dimethyl ether

C22H20O5 (364.1311)


   

2-{6-[3,4-(methylenedioxy)phenyl]-4-oxotetracyclo[5.4.2.0(3,13).0(10,12)]-trideca-5,8-dien-11-yl}acetic acid|5-(1,3-benzodioxol-5-yl)-1a,2,2a3,5a,7a,7b,7c-octahydro-3-oxo-1H-cyclobut[bc]acenaphthylene-1-acetic acid|beilschmiedic acid F

2-{6-[3,4-(methylenedioxy)phenyl]-4-oxotetracyclo[5.4.2.0(3,13).0(10,12)]-trideca-5,8-dien-11-yl}acetic acid|5-(1,3-benzodioxol-5-yl)-1a,2,2a3,5a,7a,7b,7c-octahydro-3-oxo-1H-cyclobut[bc]acenaphthylene-1-acetic acid|beilschmiedic acid F

C22H20O5 (364.1311)


   

Hypoxylonol A

Hypoxylonol A

C22H20O5 (364.1311)


   

(1S,3R,5R,7S,8S,9S)-1,3-diethoxy-5,8-dihydroxyvalechlorine|chlorovaltrate D

(1S,3R,5R,7S,8S,9S)-1,3-diethoxy-5,8-dihydroxyvalechlorine|chlorovaltrate D

C16H25ClO7 (364.1289)


   

cryptobeilic acid C

cryptobeilic acid C

C22H20O5 (364.1311)


   

4,5,7-trihydroxy-6-isopentene-2-styrylchromone|platachromone A

4,5,7-trihydroxy-6-isopentene-2-styrylchromone|platachromone A

C22H20O5 (364.1311)


   

4,5,7-trihydroxy-8-isopentene-2-styrylchromone|platachromone B

4,5,7-trihydroxy-8-isopentene-2-styrylchromone|platachromone B

C22H20O5 (364.1311)


   

CHEMBL2431354

CHEMBL2431354

C22H20O5 (364.1311)


   

Aspulvinon I

Aspulvinon I

C22H20O5 (364.1311)


   

Desepoxy-dihydroxy-galiridosid

Desepoxy-dihydroxy-galiridosid

C15H24O10 (364.1369)


   

DTXSID90716421

DTXSID90716421

C22H20O5 (364.1311)


   

2-Phenyl-7-methoxy-8-(4-oxo-5,5-dimethyl-4,5-dihydrofuran-3-yl)-2,3-dihydro-4H-1-benzopyran-4-one

2-Phenyl-7-methoxy-8-(4-oxo-5,5-dimethyl-4,5-dihydrofuran-3-yl)-2,3-dihydro-4H-1-benzopyran-4-one

C22H20O5 (364.1311)


   

Asperterone

Asperterone

C22H20O5 (364.1311)


   

clofoctol

clofoctol

C21H26Cl2O (364.1361)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use C254 - Anti-Infective Agent > C52588 - Antibacterial Agent Clofoctol is a bacteriostatic antibiotic. Clofoctol is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. Clofoctol is only functional against Gram-positive bacteria and can penetrate into human lung tissue. Clofoctol is also an inhibitor of prostate cancer. Clofoctol has antiviral potency[1][2][3].

   

C15H24O10_4a,5,7-Trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl beta-D-glucopyranoside

NCGC00347646-02_C15H24O10_4a,5,7-Trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl beta-D-glucopyranoside

C15H24O10 (364.1369)


   

7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol

7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol

C15H24O10 (364.1369)


   

7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol_major

7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol_major

C15H24O10 (364.1369)


   

7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol_57.3\\%

7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4a,5,7-triol_57.3\\%

C15H24O10 (364.1369)


   

Asp Gly Ser Ser

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H20N4O9 (364.123)


   

Asp Ser Gly Ser

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]-2-hydroxyethyl]carbamoyl}propanoic acid

C12H20N4O9 (364.123)


   

Asp Ser Ser Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C12H20N4O9 (364.123)


   

Gly Asp Ser Ser

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C12H20N4O9 (364.123)


   

Gly Ser Asp Ser

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C12H20N4O9 (364.123)


   

Gly Ser Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]butanedioic acid

C12H20N4O9 (364.123)


   
   
   
   
   
   

Ser Asp Gly Ser

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H20N4O9 (364.123)


   

Ser Asp Ser Gly

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}propanoic acid

C12H20N4O9 (364.123)


   

Ser Gly Asp Ser

(3S)-3-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C12H20N4O9 (364.123)


   

Ser Gly Ser Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]butanedioic acid

C12H20N4O9 (364.123)


   
   

Ser Ser Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C12H20N4O9 (364.123)


   

Ser Ser Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}butanedioic acid

C12H20N4O9 (364.123)


   

4a,5,7-Trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl ?-D-glucopyranoside

4a,5,7-Trihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl ?-D-glucopyranoside

C15H24O10 (364.1369)


   
   

3,5-Dibenzyloxyphenylglyoxal hydrate

3,5-Dibenzyloxyphenylglyoxal hydrate

C22H20O5 (364.1311)


   

CDPPB

CDPPB

C23H16N4O (364.1324)


CDPPB is a potent, selective and brain penetrant positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5), with an EC50 of 27 nM in Chinese hamster ovary cells expressing human mGluR5. CDPPB may provide an approach for development of antipsychotic agents[1].

   

5,6-DI(FURAN-2-YL)-3-PHENYL-[2,2]BIPYRIDINYL

5,6-DI(FURAN-2-YL)-3-PHENYL-[2,2]BIPYRIDINYL

C24H16N2O2 (364.1212)


   

Diaziquone

Carbamic acid,N,N-[2,5-bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl]bis-,C,C-diethyl ester

C16H20N4O6 (364.1383)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

Levomepromazine hydrochloride

Levomepromazine hydrochloride

C19H25ClN2OS (364.1376)


C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine

   

1-(2,4-bis-(Benzyloxy)-3,6-dihydroxyphenyl)ethanone

1-(2,4-bis-(Benzyloxy)-3,6-dihydroxyphenyl)ethanone

C22H20O5 (364.1311)


   

Tiapride hydrochloride

Tiapride hydrochloride

C15H25ClN2O4S (364.1223)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants Tiapride hydrochloride is a selective and orally active D2 and D3 dopamine receptors antagonist with IC50 values of 110-320 nM and 180 nM, respectively. Tiapride hydrochloride shows anti-dyskinetic activity and anxiolytic activity. Tiapride hydrochloride is a neuroleptic agent[1][2].

   

3,3-Diphenylalanine Hydrochloride

3,3-Diphenylalanine Hydrochloride

C18H21ClN2O4 (364.119)


   

toluene-4-sulfonic acid dibenzyl-alpha-&

toluene-4-sulfonic acid dibenzyl-alpha-&

C21H20N2O2S (364.1245)


   

Titanium diisopropoxide bis(acetylacetonate)

Titanium diisopropoxide bis(acetylacetonate)

C16H28O6Ti (364.1365)


   

5-(2-Oxo-hexahydro-thieno[3,4-D]imidazol-6-YL)-pentanoic acid (4-nitro-phenyl)-amide

5-(2-Oxo-hexahydro-thieno[3,4-D]imidazol-6-YL)-pentanoic acid (4-nitro-phenyl)-amide

C16H20N4O4S (364.1205)


   

N-(2-(3,5-difluorophenyl)-2-hydroxyacetyl)-2-ethyl-4-hydroxy-3-methylbenzohydrazide

N-(2-(3,5-difluorophenyl)-2-hydroxyacetyl)-2-ethyl-4-hydroxy-3-methylbenzohydrazide

C18H18F2N2O4 (364.1235)


   

Hydroxy Torsemide

Hydroxy Torsemide

C16H20N4O4S (364.1205)


   

4-Hydroxy Torsemide

4-Hydroxy Torsemide

C16H20N4O4S (364.1205)


   
   

2-[[2-(4-ethyl-4-methyl-2,5-dioxo-1-imidazolidinyl)-1-oxoethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide

2-[[2-(4-ethyl-4-methyl-2,5-dioxo-1-imidazolidinyl)-1-oxoethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide

C16H20N4O4S (364.1205)


   

1-(3,4-dihydro-2H-quinolin-1-yl)-2-[(4-methyl-5-phenyl-1,2,4-triazol-3-yl)thio]ethanone

1-(3,4-dihydro-2H-quinolin-1-yl)-2-[(4-methyl-5-phenyl-1,2,4-triazol-3-yl)thio]ethanone

C20H20N4OS (364.1358)


   

3,5-Dimethyl-4-isoxazolecarboxylic acid [2-(4-amino-1-methyl-2,6-dioxo-3-propyl-5-pyrimidinyl)-2-oxoethyl] ester

3,5-Dimethyl-4-isoxazolecarboxylic acid [2-(4-amino-1-methyl-2,6-dioxo-3-propyl-5-pyrimidinyl)-2-oxoethyl] ester

C16H20N4O6 (364.1383)


   
   
   
   
   
   
   

hydroxy torasemide

hydroxy torasemide

C16H20N4O4S (364.1205)


An aromatic primary alcohol resulting from the hydroxylation of the 3-methyl group of the phenyl ring of torasemide. It is a metabolite of torasemide.

   

4-hydroxy torasemide

4-hydroxy torasemide

C16H20N4O4S (364.1205)


A member of the class of phenols that is torasemide which carries a hydroxy group at position 4 of the phenyl ring. It is a metabolite of torasemide.

   
   
   

Deschloroclozapine (dihydrochloride)

Deschloroclozapine (dihydrochloride)

C18H22Cl2N4 (364.1221)


Deschloroclozapine dihydrochloride, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively. [11C]-Deschloroclozapine is developed as a promising PET tracer for DREADD imaging[1][2][3].

   

MAGL-IN-4

MAGL-IN-4

C18H21ClN2O4 (364.119)


MAGL-IN-4 is an orally active, selective and reversible monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 6.2 nM. MAGL-IN-4 can penetrate the blood-brain barrier (BBB). MAGL-IN-4 enhances endocannabinoid signaling mostly by the increase in the level of 2-AG via selective MAGL inhibition in the brain[1].

   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4as,5r)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4as,5r)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl benzoate

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl benzoate

C22H20O5 (364.1311)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(2s,3r,4s,5r,6r)-2-{[(1s,4as,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-{[(1s,4as,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

2-({4a,6,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({4a,6,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

2-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

2-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

C22H20O5 (364.1311)


   

[(1s,2s,3r,6r,10r,11s,12s)-7-(2h-1,3-benzodioxol-5-yl)-9-oxotetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,7-dien-2-yl]acetic acid

[(1s,2s,3r,6r,10r,11s,12s)-7-(2h-1,3-benzodioxol-5-yl)-9-oxotetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,7-dien-2-yl]acetic acid

C22H20O5 (364.1311)


   

(5z)-4-hydroxy-3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methylidene]furan-2-one

(5z)-4-hydroxy-3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methylidene]furan-2-one

C22H20O5 (364.1311)


   

(2r,3s,4r,5s,6s)-2-{[(1s,4ar,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5s,6s)-2-{[(1s,4ar,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(1r,3s,6br)-3-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

(1r,3s,6br)-3-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

C22H20O5 (364.1311)


   

5-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-4-[(4-hydroxyphenyl)methyl]benzene-1,3-diol

5-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-4-[(4-hydroxyphenyl)methyl]benzene-1,3-diol

C22H20O5 (364.1311)


   

(2s,3r,4s,5s,6r)-2-{[(1s,2s,4s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,2s,4s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(5z)-4-hydroxy-5-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methylidene}-3-(3-hydroxyphenyl)furan-2-one

(5z)-4-hydroxy-5-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methylidene}-3-(3-hydroxyphenyl)furan-2-one

C22H20O5 (364.1311)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

6-methoxy-3-(4-methoxyphenyl)-8,8-dimethylpyrano[2,3-h]chromen-4-one

6-methoxy-3-(4-methoxyphenyl)-8,8-dimethylpyrano[2,3-h]chromen-4-one

C22H20O5 (364.1311)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5r,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(2r,3r,4s,5s,6r)-2-{[(1s,4as,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,4as,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(2s,3r,4s,5r,6r)-2-{[(1s,2s,4s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5r,6r)-2-{[(1s,2s,4s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

2-isopropyl-4-oxo-7-(2-oxo-2-phenylethyl)chromen-5-yl acetate

2-isopropyl-4-oxo-7-(2-oxo-2-phenylethyl)chromen-5-yl acetate

C22H20O5 (364.1311)


   

(2r,3s,4s,5s,6r)-2-{[(1s,4as,5r,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4s,5s,6r)-2-{[(1s,4as,5r,6s,7r,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(2s)-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one

(2s)-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one

C22H20O5 (364.1311)


   

(2s)-5,7-dihydroxy-2-[7-(3-methylbut-2-en-1-yl)-1-benzofuran-5-yl]-2,3-dihydro-1-benzopyran-4-one

(2s)-5,7-dihydroxy-2-[7-(3-methylbut-2-en-1-yl)-1-benzofuran-5-yl]-2,3-dihydro-1-benzopyran-4-one

C22H20O5 (364.1311)


   

(2r,3r,4r,5r,6r)-2-{[(1r,4as,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5r,6r)-2-{[(1r,4as,5r,7s,7ar)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

4-hydroxy-5-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methylidene}-3-(3-hydroxyphenyl)furan-2-one

4-hydroxy-5-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methylidene}-3-(3-hydroxyphenyl)furan-2-one

C22H20O5 (364.1311)


   

2-{[6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[6,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(1r,2r,5s,8s,9s,10r,11r,12s)-11-(fluoromethyl)-5,12-dihydroxy-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadec-13-ene-9-carboxylic acid

(1r,2r,5s,8s,9s,10r,11r,12s)-11-(fluoromethyl)-5,12-dihydroxy-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadec-13-ene-9-carboxylic acid

C19H21FO6 (364.1322)


   

3,6-dimethoxy-8,8-dimethyl-2-phenylpyrano[2,3-h]chromen-4-one

3,6-dimethoxy-8,8-dimethyl-2-phenylpyrano[2,3-h]chromen-4-one

C22H20O5 (364.1311)


   

11-(fluoromethyl)-5,12-dihydroxy-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadec-13-ene-9-carboxylic acid

11-(fluoromethyl)-5,12-dihydroxy-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadec-13-ene-9-carboxylic acid

C19H21FO6 (364.1322)


   

(2s,3r,4s,5s,6r)-2-{[(1s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,5s,6r,10s)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

5,7-dihydroxy-2-[7-(3-methylbut-2-en-1-yl)-1-benzofuran-5-yl]-2,3-dihydro-1-benzopyran-4-one

5,7-dihydroxy-2-[7-(3-methylbut-2-en-1-yl)-1-benzofuran-5-yl]-2,3-dihydro-1-benzopyran-4-one

C22H20O5 (364.1311)


   

5-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-4-[(4-hydroxyphenyl)methyl]benzene-1,3-diol

5-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-4-[(4-hydroxyphenyl)methyl]benzene-1,3-diol

C22H20O5 (364.1311)


   

(6bs,7r,8s)-4,9-dihydroxy-7,8-dimethoxy-1h,2h,6bh,7h,8h-benzo[j]fluoranthen-3-one

(6bs,7r,8s)-4,9-dihydroxy-7,8-dimethoxy-1h,2h,6bh,7h,8h-benzo[j]fluoranthen-3-one

C22H20O5 (364.1311)


   

2-(hydroxymethyl)-6-({5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)oxane-3,4,5-triol

2-(hydroxymethyl)-6-({5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl}oxy)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

1,8-dihydroxy-3-methyl-2-[(4e)-2-methylhex-4-enoyl]anthracene-9,10-dione

1,8-dihydroxy-3-methyl-2-[(4e)-2-methylhex-4-enoyl]anthracene-9,10-dione

C22H20O5 (364.1311)


   

2-{[5,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[5,7-dihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-4-(4-hydroxyphenyl)furan-2,5-dione

3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]methyl}-4-(4-hydroxyphenyl)furan-2,5-dione

C22H20O5 (364.1311)


   

4-hydroxy-3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methylidene]furan-2-one

4-hydroxy-3-[3-hydroxy-4-(3-methylbut-2-en-1-yl)phenyl]-5-[(4-hydroxyphenyl)methylidene]furan-2-one

C22H20O5 (364.1311)


   

hypoxylonol d

hypoxylonol d

C22H20O5 (364.1311)


   

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl benzoate

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl benzoate

C22H20O5 (364.1311)


   

2-{[(4as,7s)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[(4as,7s)-4a,5,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

3,5-dimethoxy-8,8-dimethyl-2-phenylpyrano[2,3-h]chromen-4-one

3,5-dimethoxy-8,8-dimethyl-2-phenylpyrano[2,3-h]chromen-4-one

C22H20O5 (364.1311)


   

4,9-dihydroxy-7,8-dimethoxy-1h,2h,6bh,7h,8h-benzo[j]fluoranthen-3-one

4,9-dihydroxy-7,8-dimethoxy-1h,2h,6bh,7h,8h-benzo[j]fluoranthen-3-one

C22H20O5 (364.1311)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7s,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7s,7as)-5,6,7-trihydroxy-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

3-(2h-1,3-benzodioxol-5-yl)-7-methoxy-8-(3-methylbut-2-en-1-yl)chromen-4-one

3-(2h-1,3-benzodioxol-5-yl)-7-methoxy-8-(3-methylbut-2-en-1-yl)chromen-4-one

C22H20O5 (364.1311)


   

3-[(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)methyl]-4-(4-hydroxyphenyl)furan-2,5-dione

3-[(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)methyl]-4-(4-hydroxyphenyl)furan-2,5-dione

C22H20O5 (364.1311)


   

3-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

3-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

C22H20O5 (364.1311)


   

2-{[5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4as,6r,7r,7as)-4a,6,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4as,6r,7r,7as)-4a,6,7-trihydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H24O10 (364.1369)


   

(1r,2s,6br)-2-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

(1r,2s,6br)-2-ethoxy-1,4,9-trihydroxy-1h,2h,3h,6bh,7h-benzo[j]fluoranthen-8-one

C22H20O5 (364.1311)